Company news
Qyuns Therapeutics Co., Ltd. Class H (HKEX:2509) news
Qyuns Therapeutics Co., Ltd. Class H news releases on 6ix. Latest, Oct 2, 2026: VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL STUDY RESULTS OF OTURKIBART (QX005N)…
Press releases & updates
VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL STUDY RESULTS OF OTURKIBART (QX005N) FOR TREATMENT OF PRURIGO NODULARIS PRESENTED AS A LATE-BREAKING ORAL PRESENTATION AT EADV 2026
October 1, 2026
A Decade of Persistent Steps, Aspiring for a Thousand Miles: Qyuns' Grand 10th Anniversary Celebration Held Successfully
June 16, 2025